Good results in the lab can lead to larger human trials. Here are some of the most promising recent findings.
EGCG reduces arterial plaques -
In the late stages of fat building up in arteries, a type of a protein—apolipoprotein A-1, or apoA-1—combines with fat to form unstable plaque deposits, increasing chances for adverse events. In the lab, researchers found a compound from green tea, epigallocatechin-gallate (EGCG), binds to apoA-1 fibers, making them smaller, more soluble, and less likely to damage blood vessels. Doctors said, “Our results show that this intriguing compound might also be effective against types of...Continue
On the 1st Thursday of every month from
9:30 am - 11:00 am, Healthchek -- in partnership
with Southtown Health Foods -- brings affordable
wellness screenings and other low-cost medical
testing directly to you.